Truist Securities Adjusts Integral Ad Science Holding Price Target to $17 From $16, Maintains Buy Rating
Canaccord Genuity Upgrades Integral Diagnostics to Buy From Hold; Price Target Is AU$2.90
Bell Potter Sticks to Their Buy Rating for Integral Diagnostics Ltd. (IDX)
Integral Diagnostics Ltd. (IDX) Gets a Hold From Citi
Integral Diagnostics Price Target Cut 7.4% to A$3.15/Share by Barrenjoey
Craig-Hallum Keeps Their Buy Rating on Integral Ad Science (IAS)
Compania De Distribucion Integral Logista Holdings (0QWA) Gets a Hold From Kepler Capital
RBC Capital Remains a Buy on Integral Diagnostics Ltd. (IDX)
Integral Diagnostics Price Target Raised 1.4% to A$3.50/Share by RBC Capital Markets
Analysts Are Bullish on Top Communication Services Stocks: Meta Platforms (META), Integral Ad Science (IAS)
Integral Ad Science (IAS) Receives a Hold From Barclays
Jefferies Remains a Buy on Integral Diagnostics Ltd. (IDX)
Jefferies Starts Integral Diagnostics at Buy With AU$4.10 Price Target
Jarden Sticks to Its Buy Rating for Integral Diagnostics Ltd. (IDX)
Jarden Adjusts Integral Diagnostics' Price Target to AU$3.68 From AU$3.72, Keeps at Buy
Barclays Sticks to Their Hold Rating for Integral Ad Science (IAS)
What 5 Analyst Ratings Have To Say About Integral Ad Science
Integral Ad Science Price Target Announced at $10.00/Share by Scotiabank
Integral Ad Science Analyst Ratings
Barclays Keeps Their Buy Rating on Compania De Distribucion Integral Logista Holdings (0QWA)